Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, Australia.
Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, Australia.
Prev Med. 2023 Aug;173:107584. doi: 10.1016/j.ypmed.2023.107584. Epub 2023 Jun 20.
The extent of the preventable burden of ischaemic stroke associated with atrial fibrillation (AF) remains uncertain to date. To address this knowledge gap, we utilised the comparative risk assessment methodology to estimate the burden of ischaemic stroke associated with AF at both global and regional levels. The population attributable fraction for ischaemic stroke and AF was obtained from published literature, while data on the prevalence, incidence, deaths, and disability-adjusted life years (DALY) associated with ischaemic stroke were sourced from the Global Burden of Disease study database. Our analysis revealed that in 2019, globally, there were an estimated 0.7 (95% uncertainty interval [UI] of 0.55 to 0.83) million incident cases, 6.9 (5.81 to 8.12) million prevalence cases, 0.3 0.25 to 0.34) million deaths and 5.7 (4.91 to 6.57) million DALY resulting from ischaemic stroke associated with AF. The age-standardised death and DALY rates declined between 2009 and 2019 in all regions to varying degrees. Conversely, the age-standardised incidence and prevalence rates reduced only in high-income countries, Central Europe, Eastern Europe and Central Asia and Latin America and Caribbean regions. It is likely that our findings under-estimated the true burden of ischaemic stroke associated with AF due to limitations such as the use of a fixed population attributable fraction and poor quality of data. Nevertheless, we believe that our estimates provide valuable insights and highlight the urgent need for optimised management of AF through the implementation of efficacious interventions. Such efforts can help reduce the occurrence of preventable ischaemic strokes.
目前,与心房颤动(AF)相关的缺血性卒中可预防负担的程度仍不确定。为了弥补这一知识空白,我们利用比较风险评估方法,在全球和区域层面估算与 AF 相关的缺血性卒中负担。缺血性卒中与 AF 的人群归因分数取自已发表的文献,而缺血性卒中相关的患病率、发病率、死亡率和伤残调整生命年(DALY)的数据则取自全球疾病负担研究数据库。我们的分析表明,2019 年,全球估计有 70 万(95%置信区间 55 万至 83 万)例新发病例,690 万(581 万至 812 万)例现患病例,30 万(25 万至 34 万)例死亡和 570 万(491 万至 657 万)例 DALY 归因于与 AF 相关的缺血性卒中。在所有地区,2009 年至 2019 年,年龄标准化死亡率和 DALY 率都有所下降,尽管下降程度不一。相反,仅在高收入国家、中欧、东欧和中亚以及拉丁美洲和加勒比地区,年龄标准化发病率和患病率有所下降。由于使用固定人群归因分数和数据质量较差等限制,我们的研究结果可能低估了与 AF 相关的缺血性卒中的真实负担。尽管如此,我们认为我们的估计提供了有价值的见解,并强调了通过实施有效的干预措施优化 AF 管理的迫切需要。这些努力有助于减少可预防的缺血性卒中的发生。